Skip to content

Clinical trials

Completed Phase 2 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 2 Status: Completed Clear all

234 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20029
20038
20049
200518
200612
200719
200819
200920
201013
201113
201211
20138
201415
20156
20167
20174
20185
20196
20207
20213
20228
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed234

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University9
Otsuka Pharmaceutical Development & Commercialization, Inc.7
China Medical University Hospital6
Merck Sharp & Dohme LLC6
Nathan Kline Institute for Psychiatric Research6
Denovo Biopharma LLC5
GlaxoSmithKline5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.5
University of Maryland, Baltimore5
AstraZeneca4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia234
Psychotic Disorders67
Mental Disorders20
Bipolar Disorder12
Hallucinations8
Cognitive Dysfunction7
Schizophrenia Spectrum and Other Psychotic Disorders6
Tobacco Use Disorder5
Inflammation4
Major Depressive Disorder4

Trials

Showing 1 to 25 of 234. Each trial links to its page on Pharma Observatory.

134 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.